Onesource Specialty Pharma Limited — Important, 21-06-2025: Updates

OneSource Specialty Pharma Limited has announced a board meeting to consider the financial results for the quarter and half-year. The company has fully redeemed and successfully delisted its 20,000 secured rated non-convertible debentures (NCDs) from BSE. This move reduces debt obligations and simplifies the capital structure, potentially improving financial flexibility going forward.